Applications and Limitations of Equilibrium Density Gradient Analytical Ultracentrifugation for the Quantitative Characterization of Adeno-Associated Virus Vectors

Author:

Hirohata Kiichi1,Yamaguchi Yuki1ORCID,Maruno Takahiro1,Shibuya Risa1ORCID,Torisu Tetsuo1ORCID,Onishi Takayuki1,Chono Hideto2,Mineno Junichi2,Yuzhe Yuan3,Higashiyama Kiyoko3,Masumi-Koizumi Kyoko3,Uchida Kazuhisa3,Yamamoto Takenori4,Uchida Eriko4,Okada Takashi5,Uchiyama Susumu1ORCID

Affiliation:

1. Department of Biotechnology, Graduate School of Engineering, Osaka University, 2-1 Yamadaoka, Suita, Osaka 565-0871, Japan

2. Takara Bio Inc., 7-4-38 Nojihigashi, Kusatsu, Shiga 525-0058, Japan

3. Graduate School of Science, Technology and Innovation, Kobe University, 1-7-49 Minatojima Minamimachi, Chuo-ku, Kobe 650-0047, Japan

4. Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki-city, Kanagawa 210-9501, Japan

5. Institute of Medical Science, The University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-0071, Japan

Funder

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

Publisher

American Chemical Society (ACS)

Reference31 articles.

1. Adeno-associated virus vector as a platform for gene therapy delivery

2. Solid Biosciences. Letter to the Duchenne Community: FDA Lifts Clinical Hold on IGNITE DMD Clinical Trial. https://www.solidbio.com/about/media/news/letter-to-the-duchenne-community-fda-lifts-clinical-hold-on-ignite-dmd-clinical-trial.

3. U.S. Department of Health and Human Services Food, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for industry: Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications (INDs). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/chemistry-manufacturing-and-control-cmc-information-human-gene-therapy-investigational-new-drug.

4. Analytical methods for process and product characterization of recombinant adeno-associated virus-based gene therapies

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3